Details for New Drug Application (NDA): 019779
✉ Email this page to a colleague
The generic ingredient in IOPIDINE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.
Summary for 019779
Tradename: | IOPIDINE |
Applicant: | Harrow Eye |
Ingredient: | apraclonidine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 019779
Mechanism of Action | Adrenergic alpha-Agonists |
Suppliers and Packaging for NDA: 019779
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779 | NDA | Harrow Eye, LLC | 82667-200 | 82667-200-01 | 12 POUCH in 1 CARTON (82667-200-01) / 2 VIAL, SINGLE-DOSE in 1 POUCH / .1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 1% BASE | ||||
Approval Date: | Dec 31, 1987 | TE: | RLD: | Yes |
Expired US Patents for NDA 019779
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779-001 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Harrow Eye | IOPIDINE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019779-001 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription